US FDA’s Bipartisan Support May Offer Shelter From Political Winds, Former Chief Says

In the wake of 21st Century Cures legislation, next commissioner will have strong support across party lines to undertake smarter regulation aimed at improving the efficiency of the drug development process, former FDA head McClellan says.

Bipartisan support for the US FDA’s operations could help insulate it from adverse impacts in the current political climate, former agency commissioner Mark McClellan believes.

“Around many FDA issues there’s actually, I think, a pretty remarkable degree of bipartisan consensus about the right directions,” McClellan...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership